This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend the Oncology Professional Care Show

If you would like more information on oncology, please refer to the NHS website.

Visit the NHS website?

Sidebar CTAs

Bayer Plc

Bayer Plc

Stand: C34

Bayer aims to launch and develop products that improve people’s quality of life. To achieve this, Bayer concentrates on the research and development of innovative drugs and novel therapeutic approaches in the major therapeutic groups of cardiology, oncology, ophthalmology, haematology and gynaecological therapy.

Within oncology, the franchise includes marketed products and several compounds in various stages of clinical development. These products reflect the company’s approach to research, which prioritises targets and pathways with the potential to impact cancer treatment. Our pipeline explores specific treatment approaches for various tumours, including such common types of cancer as prostate, lung, and breast cancer, as well as advanced and rarer cancers.

PP-OTH-GB-0642 Date of Prep: July 2021


Green Park 400 South Oak Way
United Kingdom
Visit website

Contact Exhibitor

View all Exhibitors